Lenris 4mg Capsule

Lenris 4mg Capsule

Therapeutic Class:
Get Quote

Lenris 4mg Capsule is composed of the active ingredient Lenvatinib. It is a tyrosine kinase inhibitor indicated for progressive or advanced thyroid cancer when radioactive iodine therapy is not beneficial. It is also used to treat previously untreated liver cancer patients who are not eligible for surgical treatment. Anaplastic Thyroid Carcinoma (Advanced thyroid cancer) usually occurs in patients above 60 years of age. It is characterized by an enlarged and hard thyroid gland and hoarseness in the voice due to paralysis of the nerve in the voice box. Hepatocellular carcinoma (liver cancer) develops due to preexisting liver conditions such as cirrhosis or chronic hepatitis B infection. Patients who have had an allergic reaction to Lenris 4mg Capsule or any of its components should not take this medication. Patients should inform their dentist or oral surgeon that they are taking Lenris 4mg Capsule, as it can impair wound healing and increase the risk of bleeding.

Salt Composition: Lenvatinib
Strength: (4mg)
Pack Size: 10 CAP
Uses: Thyroid cancer
Table Header
Salt Composition
Lenvatinib
Strength
(4mg)
Pack Size
10 CAP
Uses
Thyroid cancer
SKU ff34e0d553fa Category
DISCLAIMER
N Chimanlal Enterprises (www.pilcare.com) is WHO GDP and ISO 9001 2015 Certified Pharmaceutical Wholesaler/ Supplier/ Exporters/ Importer from India of Lenris 4mg Capsule which is also known as Lenvatinib and Manufactured by Mylan Pharmaceuticals Pvt Ltd. It is available in strength of Lenris 4mg Capsule is supplied for Tenders/ Emergency imports/ Un – licensed, Specials, Orphan drug/ Name patient line/ RLD supplies/ Reference listed drugs/ Comparator Drug/ Bio-Similar/ Innovator samples For Clinical trials. Click to know price.

Product information is meant for

WholesalersSuppliersExportersDoctorsMOH Tender SuppliesHospitalsBrandCROsComparator SuppliesGenericCooperate SourcingIndividual PatientsIndian Institutional Buyers
Close Recently Viewed
Close
Close
Categories
×